Symbol: |
EGFEM1P
|
Description: |
EGF-like and EMI domain containing 1, pseudogene [Source:HGNC Symbol;Acc:25149]
|
Location: |
Chr3:167967310-168548387[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:109
Gene |
Compound |
Gen_sig |
Exp_pattern |
EGFEM1P |
Crotonosid |
0.03 |
Down |
EGFEM1P |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.03 |
Up |
EGFEM1P |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.029 |
Up |
EGFEM1P |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.015 |
Up |
EGFEM1P |
AT 116, benzylamine salt |
0.012 |
Down |
EGFEM1P |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.028 |
Up |
EGFEM1P |
NSC 142506 |
0.002 |
Down |
EGFEM1P |
STREPTOVARICIN G |
0.045 |
Up |
EGFEM1P |
NSC 16857 |
0.015 |
Up |
EGFEM1P |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.008 |
Up |
EGFEM1P |
NSC 23416 |
0.019 |
Up |
EGFEM1P |
Phenol, 4,4'-methylenebis[2-[(propylimino)methyl]- |
0.031 |
Down |
EGFEM1P |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.015 |
Up |
EGFEM1P |
NSC 29638 |
0.001 |
Down |
EGFEM1P |
Cycloalkannin |
0.028 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:null
SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|